DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer

Who can take part

• Documentation of Disease; o Pathologically confirmed solid tumor cancer (either most recent or new diagnosis)
• Definition of Disease [or Measurable Disease]; o Diagnosed with stages I, II, or III
• Prior Treatment; Currently undergoing systemic therapy (chemotherapy, radiation therapy, and/or immunotherapy) or within the first year following completion of systemic therapy Self-Report Criteria; Age ≥ 21 years; Lives in mainland U.S. or Puerto Rico; Identifies as Latino/a or Hispanic; Reports Spanish as their preferred language; Speaks Spanish "Very well" or "Well" as determined by the question: "How well do you speak Spanish?"; Presence of fatigue and disturbed sleep determined by a score of ≥ 3 on the MD Anderson Symptom Inventory

Who cannot take part

• o In the judgment of the treating physician, protocol investigators, and/or study staff, presence of cognitive impairment (e.g., delirium or dementia) sufficient to preclude meaningful informed consent and/or study participation
• History of comorbidities within the last 12 months associated with fatigue and poor sleep, including hypothyroidism or abnormal thyroid function, sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, alcohol or drug abuse
• Self-Report Criteria
• Pregnant or lactating, women only
• Presence of suicidal risk determined by any affirmative response on the Columbia-Suicide Severity Rating Scale

Other criteria

• Provider Eligibility Criteria:
• Participant eligibility will be determined by a self-report screener. Inclusion Criteria Self-Report Criteria
• Mental health provider
• Treats Latino cancer patients and/or survivors
• Has at least 3 years of clinical experience providing psychosocial services to cancer patients and/or survivors
• Able to read Spanish determined by the question: "Can you read in Spanish? Yes/No"; Patient Eligibility Criteria:; A patient cannot be considered eligible for this study unless ALL of the following conditions are met. Participant eligibility will be determined by an initial EMR review followed by a self-report screener